Robert G. Brodows

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

Robert J. Heine, Luc F. Van Gaal, Don Johns et al. · Annals of Internal Medicine · 2005 · 797 citations

Medicine, Endocrinology, Pharmacotherapy +17

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

Michael A. Nauck, D. Kim, Don Johns et al. · Diabetologia · 2006 · 440 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes

Bernard Zinman, Byron J. Hoogwerf, Santiago Durán García et al. · Annals of Internal Medicine · 2007 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study

T. Moretto, Terry Ridge, Leigh MacConell et al. · Clinical Therapeutics · 2008 · 351 citations

Medicine, Endocrinology, Pharmacology +17

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

Edward J. Bastyr, CA Stuart, Robert G. Brodows et al. · Diabetes Care · 2000 · 275 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17